In Brief: Advanced Tissue Sciences/Smith & Nephew
This article was originally published in The Gray Sheet
Executive Summary
Advanced Tissue Sciences/Smith & Nephew: The 50/50 joint venture formed in May 1994 ("The Gray Sheet" May 16, 1994, I&W-8) announces preclinical data on tissue engineered meniscus cartilage that show "successful healing of meniscus defects in 20 implants." The companies believe the results indicate its articular cartilage repair technology "may also apply" to meniscal repair. The joint venture partners anticipate a late 1995 or early 1996 IDE submission for articular cartilage repair...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.